Ascent Wealth Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-689
| Closed | -$242K | – | 193 |
|
|
2025
Q4 | $242K | Sell |
689
-76
| -10% | -$25.7K | 0.03% | 169 |
|
|
2025
Q3 | $247K | Sell |
765
-28
| -4% | -$8.71K | 0.03% | 166 |
|
|
2025
Q2 | $308K | Sell |
793
-267
| -25% | -$107K | 0.04% | 148 |
|
|
2025
Q1 | $461K | Buy |
1,060
+202
| +24% | +$81.1K | 0.06% | 138 |
|
|
2024
Q4 | $317K | Sell |
858
-163
| -16% | -$68.2K | 0.04% | 140 |
|
|
2024
Q3 | $531K | Sell |
1,021
-5
| -0.5% | -$2.67K | 0.07% | 119 |
|
|
2024
Q2 | $556K | Sell |
1,026
-167
| -14% | -$88.3K | 0.08% | 125 |
|
|
2024
Q1 | $619K | Buy |
1,193
+21
| +2% | +$10.4K | 0.09% | 120 |
|
|
2023
Q4 | $553K | Sell |
1,172
-6
| -0.5% | -$2.77K | 0.09% | 123 |
|
|
2023
Q3 | $513K | Buy |
1,178
+172
| +17% | +$78K | 0.09% | 123 |
|
|
2023
Q2 | $447K | Buy |
1,006
+160
| +19% | +$73.8K | 0.08% | 127 |
|
|
2023
Q1 | $389K | Buy |
846
+17
| +2% | +$8.09K | 0.08% | 128 |
|
|
2022
Q4 | $425K | Sell |
829
-160
| -16% | -$81.2K | 0.09% | 123 |
|
|
2022
Q3 | $449K | Hold |
989
| – | – | 0.11% | 112 |
|
|
2022
Q2 | $477K | Sell |
989
-29
| -3% | -$14.3K | 0.11% | 113 |
|
|
2022
Q1 | $500K | Sell |
1,018
-26
| -2% | -$11.9K | 0.09% | 112 |
|
|
2021
Q4 | $484K | Sell |
1,044
-1
| -0.1% | -$421 | 0.09% | 115 |
|
|
2021
Q3 | $390K | Buy |
1,045
+16
| +2% | +$6.08K | 0.07% | 127 |
|
|
2021
Q2 | $393K | Buy |
1,029
+66
| +7% | +$25.2K | 0.08% | 123 |
|
|
2021
Q1 | $346K | Buy |
963
+28
| +3% | +$9K | 0.08% | 102 |
|
|
2020
Q4 | $300K | Buy |
935
+103
| +12% | +$31.6K | 0.07% | 102 |
|
|
2020
Q3 | $223K | Buy |
832
+10
| +1% | +$2.69K | 0.06% | 102 |
|
|
2020
Q2 | $216K | Buy |
+822
| New | +$219K | 0.06% | 100 |
|
|
2020
Q1 | – | Sell |
-946
| Closed | -$286K | – | 116 |
|
|
2019
Q4 | $286K | Buy |
946
+38
| +4% | +$10.5K | 0.08% | 100 |
|
|
2019
Q3 | $218K | Sell |
908
-256
| -22% | -$70.1K | 0.07% | 113 |
|
|
2019
Q2 | $328K | Buy |
1,164
+179
| +18% | +$48.9K | 0.1% | 99 |
|
|
2019
Q1 | $283K | Buy |
985
+20
| +2% | +$5.78K | 0.09% | 102 |
|
|
2018
Q4 | $253K | Sell |
965
-1
| -0.1% | -$275 | 0.1% | 105 |
|
|
2018
Q3 | $265K | Buy |
966
+12
| +1% | +$3.12K | 0.08% | 115 |
|
|
2018
Q2 | $227K | Sell |
954
-10
| -1% | -$2.32K | 0.08% | 118 |
|
|
2018
Q1 | $212K | Sell |
964
-7
| -0.7% | -$1.64K | 0.08% | 119 |
|
|
2017
Q4 | $218K | Buy |
+971
| New | +$207K | 0.08% | 113 |
|
Other funds holding ELV
VCM
VPM
Ascent Wealth Partners's ELV Position: Q1 2026 in Review
Ascent Wealth Partners sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 689 shares — an estimated $242K sold.
Ascent Wealth Partners first reported a position in ELV in Q4 2017 and held it in 32 quarters. The position peaked at $619K in Q1 2024. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Ascent Wealth Partners reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Ascent Wealth Partners sold 689 Elevance Health shares in Q1 2026, an estimated $242K.
- Ascent Wealth Partners first reported a position in Elevance Health in Q4 2017 and held it in 32 quarters.
- Ascent Wealth Partners's Elevance Health position peaked at $619K in Q1 2024.
- 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Ascent Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.